🇺🇸 FDA

Company profile · Sponsor

Finch

Finch Therapeutics Group

FNCHQ · NYSE biotech BOSTON, MA, USA
Pipeline
5
Drugs
0
Patents
8

Quick answer

Finch (FNCHQ) is a biotech company. headquartered in BOSTON, MA, USA. listed on NYSE. NovaPharmaNews links 5 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker FNCHQ
Exchange NYSE
Company type biotech
Headquarters BOSTON, MA, USA
SEC CIK 0001733257

Pipeline (5)

Search pipeline →

  1. CP101

    Finch

    Recurrent C. Difficile Infection

    phase 3 mab terminated

    1 trial

  2. CP101

    Finch

    Clostridium Difficile Infection

    phase 2 mab completed

    1 trial

  3. CP101

    Finch

    Autism Spectrum Disorder

    phase 2 small molecule terminated

    1 trial

  4. Full Spectrum Microbiota

    Finch

    Clostridium Difficile Infection Recurrence

    phase 2 small molecule completed

    1 trial

  5. Fecal Microbiota Transplantation

    Finch

    Enterobacteriaceae Infections

    phase 1 mab terminated

    1 trial

Patents (8)

Search patents →

  1. US 12390496

    Methods for treating ulcerative colitis

    Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12350298

    Microbiome related immunotherapies

    Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12290538

    Methods and products for treatment of gastrointestinal disorders

    Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12285447

    Methods and compositions for treating ulcerative colitis

    Expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12161678

    Compositions for fecal floral transplantation and methods for making and using them and device for delivering them

    Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12005086

    Microbiome related immunotherapies

    Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11911419

    Compositions and methods for treating epilepsy and related disorders

    Expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11890307

    Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them

    Expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Finch?

Finch (FNCHQ) is a biotech company. headquartered in BOSTON, MA, USA. listed on NYSE. NovaPharmaNews links 5 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does Finch sponsor?

We track 5 ClinicalTrials.gov-linked programs for Finch, including CP101 and 4 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Finch company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.